Pathology of equine influenza virus (H3N8) in murine model

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Pavulraj, Selvaraj ^a   Bera, Bidhan Chandra ^a   Joshi, Alok ^b   Anand, Taruna ^a   Virmani, Meenakshi ^c   Vaid, Rajesh Kumar ^a   Shanmugasundaram, Karuppusamy ^a   Gulati, Baldev Raj ^a   Rajukumar, K ^d   Singh, Rajendra ^e   Misri, Jyoti ^f   Singh, Raj Kumar ^e   Tripathi, Bhupendra Nath ^a   Virmani, Nitin ^a  

^a NATIONAL RESEARCH CENTRE ON EQUINES   (India)

^b Veterinary Hospital Naini   (India)

^c LALA LAJPAT RAI UNIVERSITY OF VETERINARY AND ANIMAL SCIENCES   (India)

^d ICAR National Institute of High Security Animal Diseases   (India)

^e INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^f Division of Animal Science   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; DISEASE MODEL; HORSE; HORSE DISEASE; IMMUNOLOGY; INFLUENZA A VIRUS (H3N8); MOUSE; ORTHOMYXOVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; VIROLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HORSE DISEASES; HORSES; INFLUENZA A VIRUS, H3N8 SUBTYPE; MICE; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 84958012641     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143094     Document Type: Article

References (76)

1. Mumford JA, Chambers TM. Equine Influenza. In: Textbook of influenza. Blackwell Healthcare Communication; 1998. p. 146-62.
2. Gerber H. Clinical features sequelae and epidemiology of equine influenza. In: Bryans JT, Gerber H, editors. Equine Infectious Diseases II. Switzerland: S. Karger; 1970. p. 63-80.
3. Webster RG. Are equine 1 influenza viruses still present in horses? Equine Vet J. 1993; 25: 537-8. PMID: 8276003
4. OIE Terrestrial Manual 2012, Chapter 2.5.7. Equine influenza.
5. Cullinane A, Newton JR. Equine influenza-A global perspective. Vet Microbiol. 2013; 167: 205-14. doi: 10.1016/j.vetmic.2013.03.029 PMID: 23680107
6. Maher JA, De Stefano J. The ferret: an animal model to study influenza virus. Lab Anim. 2004; 33: 50-3
7. Andrewes CH, Laidlaw PP, Smith W. The susceptibility of mice to the viruses of human and swine influenza. J Exp Med. 1934; 224: 859-62.
8. Quan FS, Steinhauer D, Huang C, Ross TM, Compans RW, Kang SM. A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine. 2008; 26: 3352-61. doi: 10.1016/j.vaccine.2008.03.055 PMID: 18468740
9. Maines TR, Lu XH, Erb SM, Edwards L, Guarner J, Greer PW, et al. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol. 2005; 79(18): 11788-800. PMID: 16140756
10. Joseph T, McAuliffe J, Lu B, Jin H, Kemble G, Subbarao K. Evaluation of replication and pathogenicity of avian influenza a H7 subtype viruses in a mouse model. J Virol. 2007; 81: 10558-66. PMID: 17634234
11. Belser JA, Lu X, Maines TR, Smith C, Li Y, Donis RO, et al. Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans. J. Virol. 2007; 81: 11139-47. PMID: 17686867
12. Driskell EA, Jones CA, Stallknecht DE, Howerth EW, Tompkins SM. Avian influenza virus isolates from wild birds replicate and cause disease in a mouse model of infection. Virology. 2010; 399: 280-9. doi: 10.1016/j.virol.2010.01.005 PMID: 20123144
13. Zhu Z, Yang Y, Feng Y, Shi B, Chen L, Zheng Y, et al. Emerg Microbes Infect. 2013. August 2(8): e50. doi: 10.1038/emi.2013.50 PMID: 26038485
14. Bouvier NM, Lowen AC. Animal Models for Influenza Virus Pathogenesis and Transmission. Viruses. 2010; 2: 1530-1563. PMID: 21442033
15. Staeheli P, Grob R, Meier E, Sutcliffe JG, Haller O. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol Cell Biol. 1988; 8: 4518-23. PMID: 2903437
16. Tumpey TM, Szretter KJ, Van Hoeven N, Katz JM, Kochs G, Haller O, et al. The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol. 2007; 81: 10818-21. PMID: 17652381
17. Lu X, Tumpey TM, Morken T, Zaki SR, Cox NJ, Katz JM. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol. 1999; 73: 5903-11. PMID: 10364342
18. Belser JA, Szretter KJ, Katz JM, Tumpey TM. Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses. Adv Virus Res. 2009; 73: 55-97. doi: 10.1016/S0065-3527(09)73002-7 PMID: 19695381
19. Boon AC, de Beauchamp J, Krauss S, Rubrum A, Webb AD, Webster RG, et al. Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model. J Virol. 2010; 84: 7662-7667. doi: 10.1128/JVI.02444-09 PMID: 20484500
20. Pica N, Iyer A, Ramos I, Bouvier NM, Fernandez-Sesma A, García-Sastre A, et al. The DBA.2 Mouse Is Susceptible to Disease following Infection with a Broad, but Limited, Range of Influenza A and B Viruses. J Virol, 2011; 85(23): 12825-12829. doi: 10.1128/JVI.05930-11 PMID: 21917963
21. Boon AC. De Beauchamp J, Hollmann A, Luke J, Kotb M, Rowe S, et al. Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol. 2009; 83: 10417-10426. doi: 10.1128/JVI.00514-09 PMID: 19706712
22. Srivastava B, Błazejewska P, Heßmann M, Bruder D, Geffers R, Mauel S, et al. Host Genetic Background Strongly Influences the Response to Influenza A Virus Infections. PLoS ONE. 2009; 4(3): e4857. doi: 10.1371/journal.pone.0004857 PMID: 19293935
23. Glaser L, Conenello G, Paulson J, Palese P. Effective replication of human influenza viruses in mice lacking a major alpha 2,6 sialyltransferase. Virus Res. 2007; 126: 9-18. PMID: 17313986
24. Shinya K, Watanabe S, Ito T, Kasai N, Kawaoka Y. Adaptation of an H7N7 equine influenza A virus in mice. J Gen Virol. 2007; 88:547-53. PMID: 17251573
25. Castleman WL, Powe JR, Crawford PC, Gibbs EPJ, Dubovi EJ, Donis RO, et al. Canine H3N8 Influenza Virus Infection in Dogs and Mice. Vet Pathol. 2010; 47(3): 507-17. doi: 10.1177/0300985810363718 PMID: 20351357
26. Baz M, Paskel M, Matsuoka Y, Zengel J, Cheng X, Jin H, et al. Replication and immunogenicity of swine, equine, and avian H3 subtype influenza viruses in mice and ferrets. J Virol. 2013; 87: 6901-6910. doi: 10.1128/JVI.03520-12 PMID: 23576512
27. Baz M, Paskel M, Matsuoka Y, Zengel J, Cheng X, Treanor JJ, et al. A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets. J Virol. 2015; 89: 1652-1659. doi: 10.1128/JVI.02449-14 PMID: 25410860
28. Virmani N, Singh BK, Gulati BR, Kumar S. Equine influenza outbreak in India. Vet Rec. 2008; 163: 607-8.
29. Virmani N, Bera BC, Singh BK, Shanmugasundaram K, Gulati BR, Barua S, et al. Equine influenza outbreak in India (2008-09): Virus isolation, sero-epidemiology and phylogenetic analysis of HA gene. Vet Microbiol. 2010; 143: 224-37. doi: 10.1016/j.vetmic.2009.12.007 PMID: 20053509
30. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938; 27: 493-7.
31. Hirst GK. The agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus. Science. 1941; 94: 22. PMID: 17777315
32. Luna LD. Manual of histology staining method of armed force institute of pathology. 3rd ed. New York: McGram Hill; 1968.
33. Zhengchun L, Chambers TM, Boliar S, Branscum AJ, Sturgill TL, Timoney PJ, et al. Development and Evaluation of One-Step TaqMan Real-Time Reverse Transcription-PCR Assays Targeting Nucleoprotein, Matrix, and Hemagglutinin Genes of Equine Influenza Virus. J Clin Microbiol. 2009; 47: 3907-13. doi: 10.1128/JCM.00598-09 PMID: 19846644
34. Masanori M, Yamanaka T, Katayama Y, Niwa H, Oku K, Matsumura T, et al. Time-related Pathological Changes in Horses Experimentally Inoculated with Equine Influenza A Virus. J Equine Sci. 2012; 23: 17-26. doi: 10.1294/jes.23.17 PMID: 24833992
35. Paillot R, Prowse L, Montesso F, Huang CM, Barnes H, Escala J. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFN gamma synthesis and duration of humoral immunity. Vet Microbiol. 2013; 162:396-407. doi: 10.1016/j.vetmic.2012.10.019 PMID: 23146168
36. Mumford J, Hannant D, Jessett DM. Experimental infection of ponies with equine influenza (H3N8) viruses by intranasal inoculation or exposure to aerosols. Equine Vet J. 1990; 22: 93. PMID: 2156688
37. Mumford JA, Jessett D, Dunleavy U, Wood J, Hannant D, Sundquist B, et al. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. Vaccine. 1994a; 12:857-863.
38. Mumford JA, Wilson H, Hannant D, Jessett DM. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiol Infect. 1994b; 112: 421-437.
39. Miller WC. Equine influenza. Further observations on the "Coughing" Outbreak, 1965. Vet Rec. 1965; 77:455-456. PMID: 14331412
40. Patterson-Kane JC, Carrick JB, Axon JE, Wilkie I, Begg AP. The pathology of bronchointerstitial pneumonia in young foals associated with the first outbreak of equine influenza in Australia. Equine Vet J. 2008; 40:199-203. doi: 10.2746/042516408X292214 PMID: 18321807
41. Landolt GA, Townsend HG, Lunn DP. Equine influenza infection. Sellon DC and Long MT, editors. Equine Infectious Diseases. Missouri: Saunders; 2006.
42. Begg AP, Reece RL, Hum S, Townsend W, Gordon A, Carrick J. Pathological changes in horses dying with equine influenza in Australia, 2007. Aust Vet J. 2011; 89:19-22. doi: 10.1111/j.1751-0813.2011. 00731.x PMID: 21711275
43. Manicassamy B, Medina RA, Hai R, Tsibane T, Stertz S, Nistal Villan E, et al. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog. 2010; 6(1): e1000745. doi: 10.1371/journal.ppat.1000745 PMID: 20126449
44. Guangliang L, Zhang F, Shi J, Tian G, Chen H, Yu K, et al. A subunit vaccine candidate derived from a classic H5N1 avian influenza virus in China protects fowls and BALB/c mice from lethal challenge. Vaccine. 2013; 31: 5398-404. doi: 10.1016/j.vaccine.2013.09.009 PMID: 24055355
45. Wu J, Zhang F, Fang F, Chang H, Wang F, Yang Z, et al. Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes. Vaccine. 2010; 28: 2775-81. doi: 10.1016/j. vaccine.2010.01.037 PMID: 20117261
46. Fai LY, Tang LH, McCall AW, Ooi EE, Subbarao K. An Adjuvant for the Induction of Potent, Protective Humoral Responses to an H5N1 Influenza Virus Vaccine with Antigen-Sparing Effect in Mice. J Virol. 2010; 84: 8639-49. doi: 10.1128/JVI.00596-10 PMID: 20538850
47. Belser JA, Gustin KM, Maines TR, Blau DM, Zaki SR, Katz JM, et al. Pathogenesis and transmission of triple-reassortant swine H1N1 influenza viruses isolated before the 2009 H1N1 pandemic. J Virol. 2011; 85: 1563-1572. doi: 10.1128/JVI.02231-10 PMID: 21123386
48. Dybing JK, Schultz-Cherry S, Swayne DE, Suarez DL, Perdue ML. Distinct pathogenesis of Hong Kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J Virol. 2000; 74: 1443-1450. PMID: 10627555
49. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 2008. August 4(8):e1000115. doi: 10.1371/journal.ppat.1000115 PMID: 18670648
50. Garigliany MM, Habyarimana A, Lambrecht B, Van de Paar E, Cornet A, van den Berg T, et al. Influenza A strain-dependent pathogenesis in fatal H1N1 and H5N1 subtype infections of mice. Emerg Infect Dis. 2010; 16(4): 595-603. doi: 10.3201/eid1604.091061 PMID: 20350372
51. Teluguakula N, Yang E, Samy RP, Ng HH, Poh WP, Liew AA, et al. Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis. Am J Pathol. 2011; 179: 199-210. doi: 10.1016/j.ajpath.2011.03.013 PMID: 21703402
52. Tate MD, Brooks AG, Reading PC. Correlation between sialic acid expression and infection of murine macrophages by different strains of influenza virus. Microb Infect. 2011; 13(2): 202-7.
53. Akio MN, Sunden Y, Hattori T, Fujikura D, Nakayama Y, Miyazaki T, et al. Pathological Examination of Lung Tissues in Influenza A Virus-Infected Mice. Jpn J Infect Dis. 2012; 65: 383-91. PMID: 22996210
54. Szretter KJ, Gangappa S, Lu X, Smith C, Shieh WJ, Zaki SR, et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol. 2007; 81(6): 2736-44. PMID: 17182684
55. Xu J, Christman MC, Donis RO, Lu G. Evolutionary dynamics of influenza A nucleoprotein (NP) lineages revealed by large-scale sequence analyses. Infect Genet Evol. 2011; 11: 2125-32. doi: 10.1016/j. meegid.2011.07.002 PMID: 21763464
56. Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013; 368: 2277-85. doi: 10.1056/NEJMoa1305584 PMID: 23697469
57. Zachary TP, Aeffner F, Davis IC. Influenza A H1N1 induces declines in alveolar gas exchange in mice consistent with rapid post-infection progression from acute lung injury to ARDS. Influenza Other Respi Viruses. 2012; 7(3): 472-9.
58. Kendra W. Influenza a virus inhibits alveolar fluid clearance in BALB/c mice [Dissertation]. Ohio State University; 2012.
59. Yuen KY, Chan PKS, Peiris M, Tsang DNC, Que TL, Shortridge KF, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 1998; 351: 467-71. PMID: 9482437
60. Peiris JSM, Leung CW, Cheung CY, Ng WF, Nicholls JM. Reemergence of fatal human influenza A subtype H5N1 disease. Lancet. 2004; 363: 617-19. PMID: 14987888
61. Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, Theriault S, et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature. 2004; 431:703-7. PMID: 15470432
62. Kuiken T, Rimmelzwaan GF, Van Amerongen G, Osterhaus AD. Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis). Vet Pathol. 2003; 40: 304-10. PMID: 12724572
63. Guarner J, Paddock CD, Shieh WJ, Packard MM, Patel M, Montague JL, et al. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin Infect Dis. 2006; 43: 132-40. PMID: 16779738
64. Tang X, Chong KT. Histopathology and growth kinetics of influenza viruses (H1N1 and H3N2) in the upper and lower airways of Guinea Pigs. J Gen Virol. 2009; 90: 386-91. doi: 10.1099/vir.0.007054-0 PMID: 19141447
65. Memoli MJ, Tumpey TM, Jagger BW, Dugan VG, Sheng ZM, Qi L, et al. An early "classical" swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice. Virology. 2009; 393: 338-45. doi: 10.1016/j.virol.2009.08.021 PMID: 19733889
66. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol. 2008; 3: 499-22. PMID: 18039138
67. Mette V, Gamlem H, Gjerset B, Germundsson A, Lium B. Pathological Findings and Distribution of Pandemic Influenza A (H1N1) 2009 Virus in Lungs from Naturally Infected Fattening Pigs in Norway. Influenza Res Treat. 2011
68. Paola S, Pedini V. Localization of influenza virus sialoreceptors in equine respiratory tract. Histol Histopathol. 2008; 23: 973-8. PMID: 18498072
69. Zhang-Yong N, Luo MY, Qi WB, Yu B, Jiao PR, Liao M. Detection of expression of influenza virus receptors in tissues of BALB/c mice by histochemistry. Vet Res Commun. 2009; 33: 895-903 doi: 10.1007/s11259-009-9307-3 PMID: 19662506
70. Yu-Na L, Lee HJ, Lee DH, Kim JH, Park HM, Nahm SS, et al. Severe canine influenza in dogs correlates with hyperchemokinemia and high viral load. Virology. 2011; 417: 57-63. doi: 10.1016/j.virol. 2011.05.005 PMID: 21632085
71. To KF, Chan PK, Chan KF, Lee WK, Lam WY, Wong KF, et al. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol. 2001; 63: 242-46. PMID: 11170064
72. Nishimura H, Itamura S, Iwasaki T, Kurata T, Tashiro M. Characterization of human influenza A (H5N1) virus infection in mice: neuro-, pneumo- and adipotropic infection. J Gen Virol. 2000; 81: 2503-10. PMID: 10993940
73. Ryuta U, Kiso M, Shinya K, Goto H, Takano R, Iwatsuki-Horimoto K, et al. Virulence Determinants of Pandemic A (H1N1) 2009 Influenza Virus in a Mouse Model. J Virol. 2013; 87(4): 2226-33. doi: 10.1128/JVI.01565-12 PMID: 23221570
74. Sanjay M, Philip AT, Stoppacher R. Pathologic Findings in Novel Influenza A (H1N1) Virus ("Swine Flu") Infection. Am J Clin Pathol. 2010; 133: 380-7. doi: 10.1309/AJCPXY17SULQKSWK PMID: 20154276
75. Heldens JG, Pouwels HG, Derks CG, Van de Zande SM, Hoeijmakers MJ. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOMMatrix. Vaccine. 2010; 28: 6989-96. doi: 10.1016/j.vaccine.2010.08.043 PMID: 20728523
76. Crouch CF, Daly J, Hannant D, Wilkins J, Francis MJ. Immune responses and protective efficacy in ponies immunized with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus. Vaccine. 2004; 23: 418-25. PMID: 15530689